The biochemical pharmacology of the thymidylate synthase inhibitor, 2-desamino-2-methyl-N10-propargyl-5,8-dideazafolic acid (ICI 198583)
- 24 October 1991
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 42 (10) , 1885-1895
- https://doi.org/10.1016/0006-2952(91)90586-t
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Quinazoline antifolates inhibiting thymidylate synthase: synthesis of four oligo(L-.gamma.-glutamyl) conjugates of N10-propargyl-5,8-dideazafolic acid and their enzyme inhibitionJournal of Medicinal Chemistry, 1989
- Formation and retention and biological activity of N10-propargyl-5, 8-dideazafolic acid (CB3717) polyglutamates in L1210 cells in vitroBiochemical Pharmacology, 1988
- Development of an assay for the estimation of N10-propargyl-5,8-dideazafolic acid polyglutamates in tumor cellsAnalytical Biochemistry, 1988
- Phase I study of the antifolate N10-propargyl-5,8-dideazafolic acid, CB 3717European Journal of Cancer and Clinical Oncology, 1988
- Phase II study of the antifolate N10-propargyl-5,8-dideazafolic acid (CB 3717) in advanced breast cancerEuropean Journal of Cancer and Clinical Oncology, 1988
- Induction of remission in hepatocellular carcinoma with a new thymidylate synthase inhibitor, CB3717Journal of Hepatology, 1987
- Kinetics and mechanism of interaction of 10-propargyl-5,8-dideazafolate with thymidylate synthaseJournal of Medicinal Chemistry, 1986
- The clinical pharmacokinetics of the novel antifolate N10-propargyl-5,8-dideazafolic acid (CB 3717)Cancer Chemotherapy and Pharmacology, 1985
- Biochemical effects of a quinazoline inhibitor of thymidylate synthetase, N-(4-(N-((2-amino-4-hydroxy-6-quinazolinyl)methyl)prop-2-ynylamino)benzoyl)-l-glutamic acid (CB3717), on human lymphoblastoid cellsBiochemical Pharmacology, 1983
- A potent antitumour quinazoline inhibitor of thymidylate synthetase: Synthesis, biological properties and therapeutic results in micePublished by Elsevier ,1981